NEKTAR THERAPEUTICS (NKTR) Total liabilities 2016–2025
NEKTAR THERAPEUTICS (NKTR) total liabilities at each fiscal year-end, per SEC filings.
$190.6MFY2025 · since FY2016: $480.7M → $190.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $190.6M | -21.6% |
| FY2024 | $243.1M | -9.0% |
| FY2023 | $267.0M | -22.4% |
| FY2022 | $344.0M | -21.4% |
| FY2021 | $437.7M | -5.2% |
| FY2020 | $461.5M | -19.3% |
| FY2019 | $572.0M | +32.2% |
| FY2018 | $432.6M | +2.7% |
| FY2017 | $421.0M | -12.4% |
| FY2016 | $480.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice